Clincosm LogoSign in Get a demo

Breast Cancer

Showing NaN - NaN of 405
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer, Solid Tumor Trial in Worldwide (Inavolisib, Fulvestrant, Letrozole)

Recruiting
  • Breast Cancer
  • Solid Tumor
  • Boston, Massachusetts
  • +12 more
Jan 10, 2023

Breast Cancer Trial in Worldwide (Inavolisib, Placebo, Palbociclib)

Recruiting
  • Breast Cancer
  • Tucson, Arizona
  • +228 more
Jan 10, 2023

Breast Cancer Trial in Boston (Talazoparib, Sacituzumab Govitecan)

Recruiting
  • Breast Cancer
  • Boston, Massachusetts
  • +1 more
Jan 6, 2023

Breast Cancer Trial in Boston, Danvers (Ribociclib, Endocrine therapy)

Recruiting
  • Breast Cancer
  • Boston, Massachusetts
  • +2 more
Jan 6, 2023

Breast Cancer Trial in Boston (Acupuncture, Usual Care)

Active, not recruiting
  • Breast Cancer
  • Acupuncture
  • Usual Care
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Dec 21, 2022

Breast Cancer, Metastatic Breast Cancer, BRCA1 Gene Mutation Trial in Boston (ABT-888, temozolomide)

Active, not recruiting
  • Breast Cancer
  • +3 more
  • Boston, Massachusetts
  • +2 more
Dec 21, 2022

Breast Cancer Trial in Boston (DBT-TOBI, MRI-TOBI)

Active, not recruiting
  • Breast Cancer
  • DBT-TOBI
  • MRI-TOBI
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
Dec 21, 2022

Breast Cancer, Gastrointestinal Cancer, Gynecologic Cancer Trial in Boston (Clinician Nudge Email, Patient Nudge Letter and

Enrolling by invitation
  • Breast Cancer
  • +4 more
  • Clinician Nudge Email
  • Patient Nudge Letter and Share questionaire
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Dec 19, 2022

Breast Cancer, Prostate Cancer, Patient Engagement Trial in Boston (FOLLOW UP VISIT-TELEMEDICINE, FOLLOW UP VISIT-FACE TO FACE)

Completed
  • Breast Cancer
  • +4 more
  • FOLLOW UP VISIT-TELEMEDICINE
  • FOLLOW UP VISIT-FACE TO FACE
  • Boston, Massachusetts
  • +1 more
Dec 19, 2022

HER2-positive Breast Cancer, Invasive Carcinoma of the Breast, Breast Cancer Trial in United States (Pertuzumab+TRASTUZUMAB,

Recruiting
  • HER2-positive Breast Cancer
  • +5 more
  • Pertuzumab+TRASTUZUMAB
  • ADJUVANT ENDOCRINE THERAPY
  • Stamford, Connecticut
  • +21 more
Dec 12, 2022

Breast Cancer, HER2-positive Breast Cancer, Triple Negative Breast Cancer Trial in Boston (MRI)

Recruiting
  • Breast Cancer
  • +5 more
  • MRI
  • Boston, Massachusetts
    Brigham and Women's Hospital
Dec 9, 2022

Breast Cancer Trial in Worldwide (Ipatasertib, Placebo, Palbociclib)

Active, not recruiting
  • Breast Cancer
  • Atlanta, Georgia
  • +19 more
Dec 5, 2022

ive Alzheimer's Medicines- Anastrozole vs Exemestane/Letrozole

Active, not recruiting
  • Breast Cancer
  • Boston, Massachusetts
    Brigham and Women's Hospital
Dec 1, 2022

Breast Cancer, Non-small Cell Lung Carcinoma Trial in Worldwide (Trastuzumab deruxtecan (DS-8201a), Pembrolizumab)

Recruiting
  • Breast Cancer
  • Non-small Cell Lung Carcinoma
  • San Francisco, California
  • +24 more
Nov 30, 2022

Breast Cancer Trial in Worldwide (Dato-DXd, Capecitabine, Gemcitabine)

Active, not recruiting
  • Breast Cancer
  • Duarte, California
  • +172 more
Dec 1, 2022

Breast Cancer Trial in Worldwide (Olaparib, Placebo)

Active, not recruiting
Has Results
  • Breast Cancer
  • Anchorage, Alabama
  • +698 more
Nov 25, 2022

Breast Cancer Trial in United States (Survey)

Active, not recruiting
Has Results
  • Breast Cancer
  • Survey
  • Boston, Massachusetts
  • +5 more
Nov 22, 2022

Screening For BCRL In Targeted Therapy For Breast Cancer

Recruiting
  • Lymphedema
  • +10 more
  • Perometer
  • SOZO device
  • Boston, Massachusetts
    Massachusetts General Hospital
Nov 21, 2022

Breast Cancer Trial in United States (Photon, Proton)

Recruiting
  • Breast Cancer
  • Photon
  • Proton
  • Birmingham, Alabama
  • +40 more
Nov 18, 2022

Breast Cancer, Adherence, Medication Trial in Boston (STRIDE, Medication Monitoring Control)

Completed
Has Results
  • Breast Cancer
  • Adherence, Medication
  • STRIDE
  • Medication Monitoring Control
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
Nov 7, 2022

Breast Cancer Trial in Worldwide (exemestane, tamoxifen, triptorelin)

Active, not recruiting
Has Results
  • Breast Cancer
  • Burbank, California
  • +227 more
Nov 15, 2022

Melanoma, Prostate Cancer, Ovarian Cancer Trial in United States (Pegilodecakin, Paclitaxel or Docetaxel and Carboplatin or

Active, not recruiting
  • Melanoma
  • +8 more
  • Los Angeles, California
  • +9 more
Nov 15, 2022

Breast Cancer Trial in Worldwide (Alpelisib, Fulvestrant, Letrozole)

Active, not recruiting
  • Breast Cancer
  • Gilbert, Arizona
  • +93 more
Nov 10, 2022

Breast Cancer, Colorectal Cancer, Prostate Cancer Trial in Boston (Supervised Home-Based Exercise, Unsupervised Home-Based

Recruiting
  • Breast Cancer
  • +2 more
  • Supervised Home-Based Exercise
  • +2 more
  • Boston, Massachusetts
  • +1 more
Nov 14, 2022

Stage I Breast Cancer, Stage II Breast Cancer, Stage III Breast Cancer Trial in United States (Niraparib, Dostarlimab)

Recruiting
  • Stage I Breast Cancer
  • +7 more
  • Baltimore, Maryland
  • +6 more
Nov 11, 2022